Eric Crombez, EVP and Chief Medical Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 7,029 shares at $22.80 ($160K) on 2026-03-02, disclosed to the SEC on 2026-03-03.
Open-market sale of $160k RARE by EVP and Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ABEO | SELL | 2026-02-02 | $166K | — | Filing → |
| ABEO | SELL | 2025-08-15 | $33K | — | Filing → |
| RARE | SELL | 2025-05-05 | $29K | — | Filing → |